PLI: verschil tussen versies
Uit wikilab
(→Indicaties) |
|||
| Regel 21: | Regel 21: | ||
==Indicaties== | ==Indicaties== | ||
*Acute pancreatitis<ref>{{#pmid:22594637}}</ref> | *Acute pancreatitis<ref>{{#pmid:22594637}}</ref> | ||
| + | *Inflammatory Bowel Disease (IBD) <ref>{{#pmid: 19261082}}</ref><ref>{{#pmid: 21050218}}</ref> | ||
==Staalname== | ==Staalname== | ||
Versie van 17 apr 2013 om 14:31
| ||||||||||||||||||||||||||||||
Indicaties
Staalname
Stabiliteit
minstens 21d ongeacht de bewaartemperatuur[4]
- meerdere dagen bij 20-25 °C[5]
- meerdere weken bij 4 °C
- meerdere jaren bij (-20)-(-80) °C
Links
Referenties
- ↑ Israeli et al.: Serum pepsinogen-A, canine pancreatic lipase immunoreactivity, and C-reactive protein as prognostic markers in dogs with gastric dilatation-volvulus. J. Vet. Intern. Med. 2012;26:920-8. PMID: 22594637. DOI.
- ↑ Kathrani et al.: Elevated canine pancreatic lipase immunoreactivity concentration in dogs with inflammatory bowel disease is associated with a negative outcome. J Small Anim Pract 2009;50:126-32. PMID: 19261082. DOI.
- ↑ Bailey et al.: Comparisons between cats with normal and increased fPLI concentrations in cats diagnosed with inflammatory bowel disease. J Small Anim Pract 2010;51:484-9. PMID: 21050218. DOI.
- ↑ Steiner et al.: Stability of canine pancreatic lipase immunoreactivity concentration in serum samples and effects of long-term administration of prednisone to dogs on serum canine pancreatic lipase immunoreactivity concentrations. Am. J. Vet. Res. 2009;70:1001-5. PMID: 19645581. DOI.
- ↑ Xenoulis & Steiner: Canine and feline pancreatic lipase immunoreactivity. Vet Clin Pathol 2012;41:312-24. PMID: 22861648. DOI.
